Indications for: ELLA

Prevention of pregnancy following unprotected intercourse or known or suspected contraceptive failure. Not for use as regular contraceptive.

Adult Dosage:

Take 1 tab as soon as possible within 120hrs (5 days) after unprotected intercourse or contraceptive failure. May repeat dose if vomiting occurs within 3hrs.

Children Dosage:

Premenarchal: not applicable.

ELLA Contraindications:

Known/suspected pregnancy.

ELLA Warnings/Precautions:

Not for termination of an existing pregnancy. Exclude pregnancy before prescribing. Rule out ectopic pregnancy if lower abdominal pain occurs. Rule out pregnancy if subsequent menses delayed by >1 week. Does not protect against HIV or other STDs. Repeat use within same menstrual cycle: not recommended. Nursing mothers.

ELLA Classification:

Progesterone agonist/antagonist.

ELLA Interactions:

Avoid concomitant CYP3A4 inducers (eg, barbiturates, bosentan, carbamazepine, felbamate, griseofulvin, oxcarbazepine, phenytoin, rifampin, topiramate, St. John's wort). Potentiated by CYP3A4 inhibitors (eg, ketoconazole, itraconazole). May affect or be affected by progestin-containing contraceptives; use reliable barrier method until next menstrual cycle and resume hormonal contraception ≥5 days after dose.

Adverse Reactions:

Headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness; menstrual cycle changes.

Generic Drug Availability:


How Supplied: